4.28

6.73% 0.27

After Hours: 4.23 -0.05 -1.17%

22nd Century Group, Inc. (XXII)

Overview News Price History Option Chain Discussions Forecast Stock Split

22nd Century Group, Inc. stock is traded at $4.28, with a volume of 10,350. It is up +6.73% in the last 24 hours and down -53.74% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Previous Close:

$4.01

Open:

$4.02

24h Volume:

10,350

Relative Volume:

0.14

Market Cap:

$1.48M

Revenue:

$15.74M

Net Income/Loss:

$-12.86M

P/E Ratio:

-0.0185

EPS:

-231.1302

Net Cash Flow:

$-8.71M

1W Performance:

+9.74%

1M Performance:

-53.74%

6M Performance:

-98.46%

1Y Performance:

-99.78%

1-Day Range:

$4.00

$4.28

1-Week Range:

$3.85

$4.50

52-Week Range:

$3.74

$2,841.00

22nd Century Group, Inc. Stock (XXII) Company Profile

Name

22nd Century Group, Inc.

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

716-270-1523

Address

8560 Main Street, Williamsville, NY

Employee

Twitter

@_xxiicentury

Next Earnings Date

2026-08-13

Latest SEC Filings

XXII's Discussions on Twitter

Compare XXII vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XXII 22nd Century Group, Inc.	4.28	1.40M	15.74M	-12.86M	-8.71M	-231.13
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-22	Initiated	Alliance Global Partners	Buy
Jun-15-22	Initiated	Craig Hallum	Buy
Mar-08-22	Initiated	ROTH Capital	Buy
Jul-23-21	Initiated	Cowen	Outperform
Oct-16-17	Reiterated	Chardan Capital Markets	Buy
Aug-11-16	Reiterated	Chardan Capital Markets	Buy

View All

22nd Century Group, Inc. Stock (XXII) Latest News

Jun 26, 2026

XXII Technical Analysis | Trend, Signals & Chart Patterns - ChartMill

Jun 26, 2026

22nd Century (NASDAQ: XXII) registers 3.02M shares issuable on warrants - Stock Titan

Jun 26, 2026

Jun 25, 2026

[EFFECT] 22nd Century Group, Inc. SEC Filing - Stock Titan

Jun 25, 2026